GPT Healthcare Ltd (NSE: GPTHEALTH) Q1 2026 Earnings Call dated Aug. 07, 2025
Corporate Participants:
Unidentified Speaker
Atul Tantia — Group Chief Financial Officer
Analysts:
Unidentified Participant
Naman Bansal — Analyst
Presentation:
operator
Ladies and gentlemen, good day and welcome to GPT Healthcare Limited Q1FY26 earnings conference call. As a reminder, all participant lines will be in the listen only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing Star then zero on your touchstone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Atul Tantia Group CFO for his opening remarks. Thank you. And over to you sir.
Atul Tantia — Group Chief Financial Officer
Thank you. Good morning everyone and welcome to GPT Healthcare Limited’s earning conference call for the first quarter ended June 30, 2025. As you are aware, GPT Healthcare Limited is the healthcare arm of GPT Group and is guided by a strong sense of purpose. We are committed to delivering quality health care particularly in the underserved region of Eastern India. Through our tertiary care hospitals. We aim to bring advanced medical services closer to where people live in densely populated neighborhoods. Before we begin, I am pleased to share a significant milestone in our journey. We have moved a step closer to our goal of becoming a 1, 000 bed hospital chain.
On 2 May 2025 we commissioned a 158 bed facility at Ponchari Naka in Raipur. This facility has been established in an asset light model and is fully operational. This new hospital will not only serve Raipur but also the surrounding districts of Bilaspur, Durg and Bhilai. It offers advanced care across a wide range of specialties including cardiac sciences, Oncology, Neurology, Orthopedics, Pediatrics and more. The hospital is equipped with state of the art medical technology such as a 3 Tesla MRI, 128 size dual so CT scan, cardiac cath lab and 5 modular operation theaters designed for quarterly care and complex treatments.
This facility is supported by a team of highly skilled to healthcare professions. This also marks a proud step forward in our mission to bring world class healthcare where the people need it most. With this we now operate 719 beds across five full service multi specialty hospitals. Additionally, as we had earlier stated, we have assigned an MOU for a hospital in Jamshedpur which will have a planned capacity of 150 beds and an investment outlay of approximately 60 crores. This hospital is expected to be commissioned by the end of calendar year FY26 calendar year 26 and will further strengthen our presence in the underserved regions with quality tertiary care services.
These developments are key milestones in our mission to expand access to world class healthcare and move closer to our target of 1000 beds. Now let me mark walk you through the financial highlights for Q1 FY26 Revenue from operations grew by 9.5% to 107 crores for the quarter ended FY26 June 30 FY26 EBITDA for the quarter was rupees 18.9 crores with an EBITDA margin of 17.9% EBITDA. This was on account of initial losses for the new Raipur hospital of approximately 4.5 crores. Excluding these losses, the EBITDA would stand at our steady state. EBITDA of almost 22.
Profit after tax came in at rupees 7.7 crores with a margin of 7.7%. This was also an account of higher depreciation and interest costs for the Raipur Hospital on account of the rental paid alos improved to 3.48 days from 3.54 days a result of our ongoing effort to optimize the case mix and enhance throughput. Our RPOB stood at Rs. 38,913 aligning with our focused to serve the middle to high income segment. Approximately 94% of our business continues to come from cash and insurance patients reflecting the strong strength of our neighborhood tertiary care model. Bed occupancy overall at the network level stands at 42% due to the addition of the new hospital in Raipur.
Now coming to the hospital Wise Performance first, let’s start with Raipur which is our new hospital. Despite only one and a half months, Raipur showed an occupancy of 7% with an R prob. Of 39,188 and we are on track to achieve EBITDA break even in 1215 months. Even though it’s a new job for us, this hospital has immense potential and there is enough demand that we are sensing in the market. ILS Hospital Solid Lake, our 85 bed center of surgical excellence continues to perform well and has delivered a strong performance with ARPA further increasing to 42,003 and 13 from rupees 39,200 last year.
Coupled with increase in occupancy by 200 basis points, the changing case mix will play well and shall be visible in increased occupancy in the coming quarters. Agathala Hospital is the only corporate tertiary care hospital in the township of Thipur with 2 and 5 beds. It has 66 critical care beds and has commenced its journey towards providing comprehensive oncological services as well, the Cancer care department commenced in FY25 and the additional oncology has also commissioned in May of this year making it one of its kind. In Sapura, the occupancy of the hospital is back to 50% plus at 52% from 46%.
On its path to become a mature hospital, its new speciality sitting in the ARPA was also increased to 35,600 from 33,700 last year. The Gumdam Hospital, which has 165 beds, continues to perform well and stable. Revenue of 36 crores and an RPA of Rs. 42,684. The Havra Hospital continues to grow from a revenue and patient volume perspective with an RPOB of 35,600. We have also commenced robotic knee surgeries at this hospital. In Q1FY26. The hospital performed 12 surgeries using the robot. Our five existing hospitals, Salt Lake, Agathara, Dumnam harbor and Raipur continue to show steady progress in both financial and operational performance.
As shared earlier, we remain firmly committed to our goal of becoming a thousand bed chain in the next two years. This target reflects our broader vision of scaling up operations and bringing quality healthcare to more communities. By expanding our reach and strengthening our capabilities, we aim to enhance healthcare access and improve patient outcomes across eastern India. This vision continues to guide our strategy and reinforces our commitment to delivering excellence in health care. Thank you for your attention. With this, I conclude my opening remarks and now request the moderator to open the floor for questions. I look forward to addressing your queries regarding our performance and future outlook.
Thank you.
Questions and Answers:
operator
Thank you very much. We will now begin the question and answer session. Anyone who wishes to ask a question may please press STAR and one on their touchstone telephone. If you wish to remove yourself from the question queue, you may press STAR and two participants are requested to use hands up while asking a question. Ladies and gentlemen, we will wait for a moment while the question queue assembles. The first question is from the line of Naman Bansali from Nine Rivers Capital. Please go ahead.
Naman Bansal
Hi sir. Thank you for the opportunity. First question is on the patient volume growth in terms of IC and OP for the quarter compared to the first quarter of FY25.
Atul Tantia
Yeah, hello.
Naman Bansal
Yeah, hello. Shall I go back?
Atul Tantia
Please, please.
Naman Bansal
Sure. Second question is on Agartala which has seen good trajectory with almost 25% revenue growth and occupancy is up to 52%. Can we expect a similar ramp up for the full year and what is the guidance for that? For FY26. And lastly on Dum Dum our occupancies are at sub 60% was 70% in the previous years. What has been the ALOS day reduction here on a YOY basis? Because the revenue is almost detuned by 9% for the quarter on a y o y basis. So what are the issues that we are facing? These are the three questions.
Atul Tantia
Sure. So in terms of the IP and OP mix, the outpatient volume for the quarter was about 42,800 and comparable was 37,800 in June quarter last year the IP volume was about 7,900 compared to 7,400 last year. So that’s delta in the operation volume. The revenue has dipped slightly, but that’s again on account of a change in the case mix. We expect DUMDAM occupancy to also ramp up by the end of the year. The ALOS has reduced further to 4.59 compared to 4.62 in March. So that is again an effect of this reduction in loss that Dambam is seeing.
In terms of Agartharla, obviously we expect the case the occupancy levels to ramp up further with the radiation oncology also starting. And by March we expect the occupancy of Agatha to be closer to 60%.
Naman Bansal
Good. Thank you.
operator
Thank you sir. The next question is from the line of Ashwin Agarwal from DMeter Advisors LLP. Please go ahead.
Unidentified Participant
Hi, good morning and thank you for the opportunity. You know, I’ve been looking at your historical financials and have seen the commentary that you shared post the results. One of the things that struck me is that the revenue growth has tended to be lower than what your expectations are at most points in time. I mean last year for example, you started with roughly like 15%, ended up with plus 1%. There were a lot of one offs which were there that you had last year, including the RG CAR case, Bangladesh patient inflow and so on. But this year I would have expected on the back of a low base you would have grown at least, you know, 15, 18% or 20% on a year, on year basis.
And I’m really disappointed with the growth. How do you think you’ll be able to ramp up growth? And I mean I see the alos decline, but revenues should have to grow by 15, 18%. That’s what all the other hospitals are doing.
Atul Tantia
So for us also we are on track to do a 15% plus kind of growth for the full year. The Zaipur hospitals just started, so that’s why it was not a full quarter for them. It was just one and a half years. One and a half months. Sorry. So I think that we are still on track to achieve. [Abrupt Ending]